Neuraxpharm Buccolam Acquisition Opens Up Opportunities

Strikes Deal With Takeda For The Only Buccal Midazolam Approved Across Europe

 
• By David Wallace
  
Neuraxpharm
Neuraxpharm has struck a deal with Takeda for buccal midazolam • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business